KRT19 and Huntington disease: As the assay is highly specific (no expression in HD), CK19_LC positive samples (5.0%) will most likely contain epithelial CTCs [23]; nevertheless, CK19 TaqManTM qPCR achieved a higher positivity rate (15.5%) due to the target-specific pre-amplification step.